Skip to main content
Fig. 4 | BMC Complementary Medicine and Therapies

Fig. 4

From: Mitigation of intrahepatic cholestasis induced by 17α-ethinylestradiol via nanoformulation of Silybum marianum L.

Fig. 4

Effect of SM or nano-SM on hepatic (A) MDA, (B) GSH, and (C) CAT contents. The results are presented as means ± SE. a, b, c, d Significant difference from normal, EE, EE + UDCA, and EE + SM groups at p < 0.05, respectively. EE: 17α-ethinylestradiol; UDCA: Ursodeoxycholic acid; SM: Silybum marianum L.; MDA: malondialdehyde; GSH: reduced glutathione; CAT: catalase

Back to article page

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us